Literature DB >> 30707243

[Cardiomyopathy in a 22-year-old man with a long history of methamphetamine abuse].

D M Schwab1, H A Katus2, P W Raake2.   

Abstract

This article presents the case of a 22-year-old male patient with cardiomyopathy associated with a long history of methamphetamine abuse. Echocardiography revealed a dilated cardiomyopathy with highly reduced systolic pump function and severe mitral valve regurgitation. Inotropic treatment and MitraClip® (Abbott Vascular, Santa Clara, CA, USA) implantation resulted in enhancement of hemodynamics. The rising prevalence of methamphetamine abuse should give reason to raise awareness for the diagnostic work-up and patient history particularly in cases of unexplained cardiomyopathy in young patients.

Entities:  

Keywords:  Cardiotonic agents; Dobutamine; Heart failure, systolic; Mitral valve insufficiency; Substance-related disorders

Mesh：

Substances：

Year:  2019        PMID： 30707243     DOI： 10.1007/s00108-019-0559-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  6 in total

Review 1.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Cardiac lesions in intravenous drug addicts.

Authors:  J Rajs; B Falconer
Journal:  Forensic Sci Int       Date:  1979 May-Jun       Impact factor: 2.395

3.  Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.

Authors:  Arturo Evangelista; J Alberto San Román; Francisco Calvo; Ariana González; Juan José Gómez Doblas; Ana Revilla; Juan Antonio Castillo; Carlos González; Juan José Gómez Doblas; Teresa López Fernández; Manuel Barreiro; María José Oliva; Laura Galian Gay; Ana Serrador; Pilar Jiménez Quevedo; Manuel Pan; Miguel A Arnau Vives; Javier López Díaz; Xavier Borrás Pérez; Alberto San Román; Fernando Alfonso; Arturo Evangelista; Ignacio Ferreira-González; Manuel Jiménez Navarro; Francisco Marín; Leopoldo Pérez de Isla; Luis Rodríguez Padial; Pedro Luis Sánchez Fernández; Alessandro Sionis; Rafael Vázquez García
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2018-02

4.  Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Authors:  Javier E Lopez; Khung Yeo; Gary Caputo; Michael Buonocore; Saul Schaefer
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-11       Impact factor: 5.364

Review 5.  The Cardiac Complications of Methamphetamines.

Authors:  Elizabeth D Paratz; Neil J Cunningham; Andrew I MacIsaac
Journal:  Heart Lung Circ       Date:  2015-11-28       Impact factor: 2.975

6.  Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy.

Authors:  Stephan Schürer; Karin Klingel; Marcus Sandri; Nicolas Majunke; Christian Besler; Reinhard Kandolf; Philipp Lurz; Michael Luck; Pia Hertel; Gerhard Schuler; Axel Linke; Norman Mangner
Journal:  JACC Heart Fail       Date:  2017-06       Impact factor: 12.035
  6 in total
  1 in total

1.  Early onset cardiovascular disease related to methamphetamine use is most striking in individuals under 30: A retrospective chart review.

Authors:  Vinita Batra; Kevin S Murnane; Brianne Knox; Amber N Edinoff; Yahya Ghaffar; Laura Nussdorf; Murray Petersen; Sarah E Kaufman; Sania Jiwani; Christopher A Casey; Stephanie Terhoeve; Mohammad Alfrad Nobel Bhuiyan; Paari Dominic; Shawn McNeil; James Patterson
Journal:  Addict Behav Rep       Date:  2022-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.